Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 1
1969 3
1970 1
1972 1
1973 2
1974 3
1976 2
1977 2
1978 3
1979 1
1980 1
1981 1
1982 1
1983 3
1984 4
1985 2
1986 1
1987 2
1988 3
1989 6
1990 14
1991 5
1992 19
1993 21
1994 15
1995 27
1996 15
1997 15
1998 39
1999 31
2000 29
2001 27
2002 28
2003 44
2004 28
2005 10
2006 3
2007 2
2008 7
2009 1
2010 2
2012 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

426 results

Results by year

Filters applied: . Clear all
Page 1
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.
Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators; Van De Werf F, Adgey J, Ardissino D, Armstrong PW, Aylward P, Barbash G, Betriu A, Binbrek AS, Califf R, Diaz R, Fanebust R, Fox K, Granger C, Heikkilä J, Husted S, Jansky P, Langer A, Lupi E, Maseri A, Meyer J, Mlczoch J, Mocceti D, Myburgh D, Oto A, Paolasso E, Pehrsson K, Seabra-Gomes R, Soares-Piegas L, Sùgrue D, Tendera M, Topol E, Toutouzas P, Vahanian A, Verheugt F, Wallentin L, White H. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators, et al. Among authors: toutouzas p. Lancet. 1999 Aug 28;354(9180):716-22. doi: 10.1016/s0140-6736(99)07403-6. Lancet. 1999. PMID: 10475182 Clinical Trial.
Thermography of the cardiovascular system.
Stefanadis C, Toutouzas K, Vaina S, Vavuranakis M, Toutouzas P. Stefanadis C, et al. Among authors: toutouzas p. J Interv Cardiol. 2002 Dec;15(6):461-6. doi: 10.1111/j.1540-8183.2002.tb01089.x. J Interv Cardiol. 2002. PMID: 12476648 Review.
Medical treatment of the aorta. II.
Toutouzas P. Toutouzas P. Cardiol Clin. 1999 Nov;17(4):717-37, viii-ix. doi: 10.1016/s0733-8651(05)70110-7. Cardiol Clin. 1999. PMID: 10589341 Review.
A clinical appraisal of left atrial function.
Stefanadis C, Dernellis J, Toutouzas P. Stefanadis C, et al. Among authors: toutouzas p. Eur Heart J. 2001 Jan;22(1):22-36. doi: 10.1053/euhj.1999.2581. Eur Heart J. 2001. PMID: 11133207 Review. No abstract available.
L-Arginine in coronary atherosclerosis.
Tentolouris C, Tousoulis D, Goumas G, Stefanadis C, Davies G, Toutouzas P. Tentolouris C, et al. Among authors: toutouzas p. Int J Cardiol. 2000 Sep 15;75(2-3):123-8. doi: 10.1016/s0167-5273(00)00320-x. Int J Cardiol. 2000. PMID: 11077122 Review.
L-arginine in cardiovascular disease: dream or reality?
Tousoulis D, Antoniades C, Tentolouris C, Goumas G, Stefanadis C, Toutouzas P. Tousoulis D, et al. Among authors: toutouzas p. Vasc Med. 2002 Aug;7(3):203-11. doi: 10.1191/1358863x02vm434ra. Vasc Med. 2002. PMID: 12553744 Review.
Vulnerable plaque: the challenge to identify and treat it.
Stefanadis C, Vavuranakis M, Toutouzas P. Stefanadis C, et al. Among authors: toutouzas p. J Interv Cardiol. 2003 Jun;16(3):273-80. doi: 10.1034/j.1600-0854.2003.8043.x. J Interv Cardiol. 2003. PMID: 12800407 Review.
Nitric oxide synthesis in atherosclerosis.
Toutouzas PC, Tousoulis D, Davies GJ. Toutouzas PC, et al. Eur Heart J. 1998 Oct;19(10):1504-11. doi: 10.1053/euhj.1998.1087. Eur Heart J. 1998. PMID: 9820988 Review. No abstract available.
426 results